Roger Kornberg - Oct 9, 2024 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role: Director
Signature: /s/ Roger Kornberg
Stock symbol: COCP
Transactions as of: Oct 9, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/11/2024, 04:06 PM
Previous filing: Dec 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCP	Common Stock	Award		+28.1K			28.1K	Oct 9, 2024	Direct	F1
holding	COCP	Common Stock						39.8K	Oct 9, 2024	By Kornberg-Lorch Living Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan.
F2	These shares are held by Kornberg-Lorch Living Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the securities held by Kornberg-Lorch Living Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan.

These shares are held by Kornberg-Lorch Living Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the securities held by Kornberg-Lorch Living Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.